Enhancing Hypnotic Medication Discontinuation in Primary Care — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Enhancing Hypnotic Medication Discontinuation in Primary Care — Stella

Recruiting

Back to Insomnia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

National Jewish Health, Denver, Colorado

Key details

Phase

Post-approval study

Sponsor

National Jewish Health

Enrollment target

~430 participants

Started

January 2025

Primary completion

June 2028

Age range

21 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov